A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

NCT07122414 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-muscle Invasive Bladder Cancer (NMIBC)

Interventions

DRUG: FL115
DRUG: FL115+BCG

Sponsor

Suzhou Forlong Biotechnology Co., Ltd